EIF2AK3 and melanoma: In another study on melanoma, PERK loss in cancer cells promoted immunogenic cell death and IFN production in DCs, converting them into inflammatory cells that then stimulate the infiltration of CD8 + T cells, resulting in enhanced anti-tumor immunity.